HEILMITTELWERBEGESETZ 2010 PDF

But partners in Europe say that Germany must be more generous to avoid the collapse of the Euro. Sickness funds offer benefits packages covering prevention, screening, treatment and sick pay not covered by employers. Comparative advertising to healthcare professionals must not be misleading and the compared products must be similar. Heilmittelwerrbegesetz is significant that last year, BI and Lilly decided not to launch their new diabetes drug Trajenta in Germany, blaming price controls.

Author:Tojagore Kagasar
Country:Poland
Language:English (Spanish)
Genre:Health and Food
Published (Last):14 November 2011
Pages:188
PDF File Size:2.45 Mb
ePub File Size:4.28 Mb
ISBN:299-9-17922-365-5
Downloads:59318
Price:Free* [*Free Regsitration Required]
Uploader:Dinris



But partners in Europe say that Germany must be more generous to avoid the collapse of the Euro. Sickness funds offer benefits packages covering prevention, screening, treatment and sick pay not covered by employers. Comparative advertising to healthcare professionals must not be misleading and the compared products must be similar. Heilmittelwerrbegesetz is significant that last year, BI and Lilly decided not to launch their new diabetes drug Trajenta in Germany, blaming price controls.

Under the equivalence principle, the fee paid by a pharmaceutical manufacturer for the service provided by a health care professional must correspond to the market value of the service. They generally seek injunctive relief to stop advertisements violating their rights on the basis of the UWG. There is no legal heilmittelwerbegesets to disclose the transfer heilmittelwerbegessetz values to healthcare professionals in Germany. Under to the separation principle, the fees paid by a pharmaceutical manufacturer for a service provided by a health care professional must not constitute an incentive to recommend, prescribe, purchase, supply, sell or administer specific medicinal products.

Heilmittelwerbegesetz by Germany and Ulf Doepner , Book This concerns the organisational structure of pharmaceutical and other companies in relation heilmitrelwerbegesetz a proper delegation and ongoing supervision and control by board members.

As long as the documentation effort for the particular physician remains within a timeframe of 15 to heilmitrelwerbegesetz minutes, a lump sum currently EUR These additional requirements do not apply to advertising activities which are only aimed at healthcare professionals. German law on advertising medicinal products does not foresee any specific regulation relating to refund schemes.

The negligent breach of these regulations may be punished by an administrative fine of up to EUR 20, In the public heilmitteelwerbegesetz it accounts for 30 per cent in value and per cent in volume.

The recommendations include specific guidelines on the interaction heilmittelwerbevesetz the pharmaceutical industry and other decision-makers in the healthcare sector. As a result, pharmaceutical companies must make available to the public a list of the patient organisations that are financially supported in Germany and throughout Europe, or that receive indirect or non-financial benefits.

Country report: The healthcare market in Germany The samples cannot be larger than the smallest presentation of the medicinal product on the market. Section 4 17 of the AMG defines placing on the market as keeping the product in stock for sale or for other forms of supply, the exhibition and offering for sale and the distribution to others.

If so, what companies are affected i. The authorisation to distribute prescription drugs in pharmacies can be granted as well if the applying pharmacist states that he or she operates a pharmacy in another member state of the EU.

German Statistics Office, excludes stillborn cases and judicial causes To respond to ageing of the population, a long-term care insurance scheme was created in The supply of such samples must be recorded by the company. Whether such exceptions apply has to be assessed on a case-by-case basis. Campaigns aimed at physicians to promote new products are appropriate but reaching patients is only possible through disease awareness initiatives, as only indications and balanced information about all therapeutic options can be mentioned.

In the event of a conflict of the applicable codes, the more restrictive code will apply. A claimant can request a corrective statement or the communication or publication of the judgment to third parties. Accordingly, courts have interpreted the legislation in this way. Nearly 50 per cent of doctors use social media, so there are opportunities here, but restrictions in promotional tools still apply and content needs to be maintained and monitored.

Under section 64 3 of the Medicinal Products Act Arzneimittelgesetz AMGthe competent authority must ensure that the provisions relating to advertisements of medicines are observed. Vfa claims that up to prices for pharmaceuticals barely changed but since then they have decreased significantly. According to the new Section 15a FSA-Code of Conduct, member companies may only provide healthcare professionals with:.

The collaboration of member companies with patient organisations must not involve recommendations for individual prescription-only pharmaceuticals or groups of pharmaceuticals and the appearance of member company representatives at patient organisations must not be aimed at making promotional references to prescription-only pharmaceuticals. Back to top of page Biotech There are biotech clusters in Munich, Heidelberg and Cologne, and companies in this sector have had government support, although government regulations, for example on the use of stem cells, remain restrictive.

If there is a medical rationale for providing an item to the patient which is either necessary for the administration of the medicinal product or which supports the overall compliance of the patient, this may also qualify as an accessory to the goods which is customary in the trade. Hospitality and Related Payments.

In Section 1 HWG, a new paragraph 7 has been added: Member companies are not allowed to establish own patient organisations. In the case of non-compliance, penalties can be imprisonment for a term not exceeding three years or a fine. Heilmittelwerbegesetz Inside EU Life Sciences The stipulated compensation must be reasonable with respect to the services to be rendered. Cross-border sales Medicinal products only available on prescription can only be mailed to other member states of the EU.

Such information and consent shall be mandatory where this is required under data protection laws. In principle, the decisions or other measures of self-regulatory bodies e. Related Posts.

2SC5296 DATASHEET PDF

Gesetz ├╝ber die Werbung auf dem Gebiete des Heilwesens

Dulkis What rules govern such studies? The following marketing activities in relation to consumers are prohibited, among others section 11 1Advertisement of Healthcare Products Act Heilmittelwerbegesetz HWG:. It is not permitted to provide consumers with free samples of drugs section 11 1 No. There is a simplified licence procedure for parallel imported drugs that have already been licensed for national distribution in another EU country.

BAL WP1 PDF

HEILMITTELWERBEGESETZ 2010 PDF

Tausida Carolin Kemmner Clifford Chance. In principle, the above rules with respect to the offering and granting of gifts and other benefits to healthcare professionals also apply to medical institutions. Opposition to these procedures is possible as well as an appeal to the administrative courts Verwaltungsgericht against the decisions of medical associations and associations of statutory health insurance registered doctors. The number of doctors and nurses per 1, inhabitants is high but fewer medical professionals are graduating, leading to a recruitment issue. Moreover, it is possible that competitors will contact enforcement functions to initiate an investigation in addition to seeking incentive relief regarding deviant behaviour. Unquantifiable added benefit 5.

Related Articles